BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23226332)

  • 21. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A; Seyedna SY; Nazemalhosseini Mojarad E; Majd A; Asadzadeh Aghdaei H
    J Cell Physiol; 2019 Aug; 234(8):13128-13136. PubMed ID: 30549036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity.
    Iwaizumi M; Tseng-Rogenski S; Carethers JM
    Mutat Res; 2013; 747-748():19-27. PubMed ID: 23643670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated microsatellite alterations at selected tetranucleotides (EMAST) and mismatch repair gene expression in prostate cancer.
    Burger M; Denzinger S; Hammerschmied CG; Tannapfel A; Obermann EC; Wieland WF; Hartmann A; Stoehr R
    J Mol Med (Berl); 2006 Oct; 84(10):833-41. PubMed ID: 16924473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in colorectal cancers.
    Laycock A; Kang A; Ang S; Texler M; Bentel J
    Hum Pathol; 2021 Dec; 118():9-17. PubMed ID: 34537247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas.
    Yin J; Kong D; Wang S; Zou TT; Souza RF; Smolinski KN; Lynch PM; Hamilton SR; Sugimura H; Powell SM; Young J; Abraham JM; Meltzer SJ
    Hum Mutat; 1997; 10(6):474-8. PubMed ID: 9401011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation.
    Plaschke J; Krüger S; Pistorius S; Theissig F; Saeger HD; Schackert HK
    Int J Cancer; 2002 Feb; 97(5):643-8. PubMed ID: 11807791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability and mutations in DNA mismatch repair genes in sporadic colorectal cancers.
    Jeong SY; Shin KH; Shin JH; Ku JL; Shin YK; Park SY; Kim WH; Park JG
    Dis Colon Rectum; 2003 Aug; 46(8):1069-77. PubMed ID: 12907901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EMAST status as a beneficial predictor of fluorouracil-based adjuvant chemotherapy for Stage II/III colorectal cancer.
    Mohammadpour S; Goodarzi HR; Jafarinia M; Porhoseingholi MA; Nazemalhosseini-Mojarad E
    J Cell Physiol; 2020 Apr; 235(4):3604-3611. PubMed ID: 31549400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of germline and somatic mutations in 16 genes associated with mismatch repair function or containing tandem repeat sequences.
    Chang SC; Lan YT; Lin PC; Yang SH; Lin CH; Liang WY; Chen WS; Jiang JK; Lin JK
    Cancer Med; 2020 Jan; 9(2):476-486. PubMed ID: 31769227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability at tetranucleotide repeats in sporadic colorectal cancer in Japan.
    Yamada K; Kanazawa S; Koike J; Sugiyama H; Xu C; Funahashi K; Boland CR; Koi M; Hemmi H
    Oncol Rep; 2010 Feb; 23(2):551-61. PubMed ID: 20043121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EMAST Type of Microsatellite Instability-A Distinct Entity or Blurred Overlap between Stable and MSI Tumors.
    Vuković Đerfi K; Salar A; Cacev T; Kapitanović S
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Human DNA Mismatch Repair Protein MSH3 Contains Nuclear Localization and Export Signals That Enable Nuclear-Cytosolic Shuttling in Response to Inflammation.
    Tseng-Rogenski SS; Munakata K; Choi DY; Martin PK; Mehta S; Koi M; Zheng W; Zhang Y; Carethers JM
    Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors.
    Gras E; Catasus L; Argüelles R; Moreno-Bueno G; Palacios J; Gamallo C; Matias-Guiu X; Prat J
    Cancer; 2001 Dec; 92(11):2829-36. PubMed ID: 11753956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hMSH3 and hMSH6 in ovarian endometrioid carcinoma and relationship with microsatellite instability phenotype.
    Albarracin CT; Silva EG; Malpica A; Luthra R; Liu J
    Oncol Rep; 2004 Dec; 12(6):1217-9. PubMed ID: 15547740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological Features with DNA Microsatellite Alterations in Patients with Colorectal Cancer.
    Raeker MO; Carethers JM
    J Cancer Immunol (Wilmington); 2020; 2(3):116-127. PubMed ID: 33000102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability and suppressed DNA repair enzyme expression in rheumatoid arthritis.
    Lee SH; Chang DK; Goel A; Boland CR; Bugbee W; Boyle DL; Firestein GS
    J Immunol; 2003 Feb; 170(4):2214-20. PubMed ID: 12574395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HEREDITARY, SPORADIC AND METASTATIC COLORECTAL CANCER ARE COMMONLY DRIVEN BY SPECIFIC SPECTRUMS OF DEFECTIVE DNA MISMATCH REPAIR COMPONENTS.
    Carethers JM
    Trans Am Clin Climatol Assoc; 2016; 127():81-97. PubMed ID: 28066040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
    Catto JW; Azzouzi AR; Amira N; Rehman I; Feeley KM; Cross SS; Fromont G; Sibony M; Hamdy FC; Cussenot O; Meuth M
    Oncogene; 2003 Nov; 22(54):8699-706. PubMed ID: 14647464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.